1 Min Read
March 8 (Reuters) - Pacira Pharmaceuticals Inc:
* Pacira Pharmaceuticals announces pricing of $300 million aggregate principal amount of 2.375% convertible senior notes due 2022 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.